Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Exmceuticals Inc C.EXM

Healthcare
EXMceuticals Inc. is a bio-sciences company that is focused on the production of cannabinoid formulations. The Company operates through its geographic segments, which include Canada, Portugal, Uganda and Netherlands. The Company’s subsidiaries include EXMceuticals Inc., EXMceuticals Holdings B.V, EXMceuticals Portugal, LDA and EXMceuticals Portugal II, Unipessoal Lda.

Opinion & Analysis (CSE:EXM)

    BioNTech, CureVac, EXMceuticals - reaching their goal with government support

    Mario Hose September 18, 2020

    EQS Group, EXMceuticals, Media and Games Invest - Buy recommendations from the experts

    Mario Hose August 20, 2020

    EXMceuticals, Nebelhornbahn, Syzygy - where entry opportunities now exist

    Mario Hose August 14, 2020

    BioNTech, Eastman Kodak, EXMceuticals - investors have the chance to profit

    Mario Hose July 29, 2020

    BioNTech, EXMceuticals, XPhyto - Covid-19 and legalizations offer potential

    Mario Hose July 15, 2020

    BioNTech, Evotec, EXMceuticals - which stocks have the potential to double?

    Mario Hose June 18, 2020

    Aphria, Aurora Cannabis, Canopy Growth, EXMceuticals - do not miss the entry!

    Mario Hose May 19, 2020

    BioNTech, EXMceuticals, Shop Apotheke Europe, Symrise - Shares gaining momentum

    Mario Hose May 14, 2020

    Allianz, Commerzbank, TUI, Wirecard - and news for investors

    Mario Hose May 8, 2020

    Burcon Nutrascience, Enthusiast Gaming, EXMceuticals - Investing in the future

    Mario Hose April 28, 2020

    Bayer, EXMceuticals, Symrise - investing in the healthcare growth market

    Mario Hose April 20, 2020

    BioNTech, Evotec, EXMceuticals - Stocks with potential

    Mario Hose April 15, 2020

    Aurora Cannabis, Bayer, EXMceuticals - ready for the time after Corona

    Mario Hose March 23, 2020

    Aurora Cannabis, Canopy Growth, EXMceuticals - who will be the best turnaround story?

    Mario Hose February 25, 2020

    Aphria, Canopy Growth, EXMceuticals - Europe becomes the largest cannabis market

    Mario Hose February 11, 2020

    Aurora Cannabis, EXMceuticals, Tilray - Cannabis development in Portugal

    Mario Hose February 4, 2020

    Aphria, Cronos Group, EXMceuticals - it is a buyers' market!

    Mario Hose January 21, 2020

    Aurora Cannabis, Canopy Growth, Exmceuticals - Profits With Turnaround

    Mario Hose January 16, 2020